XML 18 R8.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 41,025 $ 57,345
Adjustments to reconcile net income to net cash provided by operating activities:    
Gain on disposition of property (120) (181)
Depreciation and amortization of deferred leasing costs 42,727 36,102
Amortization of deferred debt costs 2,108 1,722
Non-cash share-based compensation costs 1,429 1,330
Credit losses on operating lease receivables, net 1,005 531
Increase in accounts receivable and accrued income (8,761) (4,323)
Additions to deferred leasing costs (3,258) (4,920)
Increase in other assets (2,811) (1,770)
Increase in accounts payable, accrued expenses, and other liabilities 3,885 471
Increase in deferred income 380 6,141
Net cash provided by operating activities 77,609 92,448
Cash flows from investing activities:    
Acquisitions of real estate investments (31) 0
Additions to real estate investments (21,547) (20,773)
Additions to development and redevelopment projects (52,651) (124,419)
Proceeds from disposition of property 120 181
Net cash used in investing activities (74,109) (145,011)
Cash flows from financing activities:    
Proceeds from mortgage notes payable 0 170,000
Repayments on mortgage notes payable (26,554) (76,423)
Proceeds from term loan facility 40,000 0
Proceeds from revolving credit facility 99,500 85,000
Repayments on revolving credit facility (96,500) (173,000)
Proceeds from construction loans payable 42,834 101,017
Additions to deferred debt costs (6,076) (2,674)
Proceeds from the issuance of:    
Common stock 1,770 1,785
Partnership units 12,971 14,862
Distributions to:    
Common stockholders (42,848) (42,642)
Noncontrolling interests (18,712) (18,176)
Net cash provided by (used in) financing activities (2,011) 51,353
Net increase (decrease) in cash and cash equivalents 1,489 (1,210)
Cash and cash equivalents, beginning of period 10,299 8,407
Cash and cash equivalents, end of period 11,788 7,197
Supplemental disclosure of cash flow information:    
Cash paid for interest 48,598 35,572
Accrued capital expenditures included in accounts payable, accrued expenses, and other liabilities 17,684 32,884
Series D preferred stockholders    
Distributions to:    
Preferred stockholders (3,446) (3,446)
Series E preferred stockholders    
Distributions to:    
Preferred stockholders $ (4,950) $ (4,950)